BeiGene
ONC
390.94
-8.76
-2.19%
BeiGene
US · ONC
#538 by market cap
Listed 2016
390.94
-8.76
-2.19%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About BeiGene
BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
- Founded
- 2010
- CEO
- Mr. John V. Oyler
- Employees
- 12,000
- Headquarters
- Basel, Basel-Landschaft (Basle Country), Switzerland
- Fiscal year end
- 12-31
- Website
- beonemedicines.com
Company profile
- Exchange
- US
- Symbol
- ONC
- Market-cap rank
- #538
- Listing date
- 2016-02-03
- Market cap
- 44.66B
- Float cap
- 31.65B
- Shares out
- 114.23M
- Float shares
- 80.95M
Sectors & themes
Biotechnology
HK ADR
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
BeiGene discussion 0 comments